170 related articles for article (PubMed ID: 31400228)
21. Extracorporeal Life Support Bridge to Ventricular Assist Device: The Double Bridge Strategy.
Marasco SF; Lo C; Murphy D; Summerhayes R; Quayle M; Zimmet A; Bailey M
Artif Organs; 2016 Jan; 40(1):100-6. PubMed ID: 25980985
[TBL] [Abstract][Full Text] [Related]
22. Comorbidities and the decision to undergo or forego destination therapy left ventricular assist device implantation: An analysis from the Trial of a Shared Decision Support Intervention for Patients and their Caregivers Offered Destination Therapy for End-Stage Heart Failure (DECIDE-LVAD) study.
Warraich HJ; Allen LA; Blue LJ; Chaussee EL; Thompson JS; McIlvennan CK; Flint KM; Matlock DD; Patel CB
Am Heart J; 2019 Jul; 213():91-96. PubMed ID: 31129442
[TBL] [Abstract][Full Text] [Related]
23. Improved Nutrition Status in Patients With Advanced Heart Failure Implanted With a Left Ventricular Assist Device.
Genev I; Yost G; Gregory M; Gomez K; Pappas P; Tatooles A; Bhat G
Nutr Clin Pract; 2019 Jun; 34(3):444-449. PubMed ID: 30644613
[TBL] [Abstract][Full Text] [Related]
24. Neurohormonal regulation and improvement in blood glucose control: reduction of insulin requirement in patients with a nonpulsatile ventricular assist device.
Koerner MM; El-Banayosy A; Eleuteri K; Kline C; Stephenson E; Pae W; Ghodsizad A
Heart Surg Forum; 2014 Apr; 17(2):E98-102. PubMed ID: 24808450
[TBL] [Abstract][Full Text] [Related]
25. Delivery of End-of-Life Care in Patients Requesting Withdrawal of a Left Ventricular Assist Device Using Intranasal Opioids and Benzodiazepines.
Wiens EJ; Pilkey J; Wong JK
J Palliat Care; 2019 Apr; 34(2):92-95. PubMed ID: 30755087
[TBL] [Abstract][Full Text] [Related]
26. Device Therapy and Arrhythmia Management in Left Ventricular Assist Device Recipients: A Scientific Statement From the American Heart Association.
Gopinathannair R; Cornwell WK; Dukes JW; Ellis CR; Hickey KT; Joglar JA; Pagani FD; Roukoz H; Slaughter MS; Patton KK
Circulation; 2019 May; 139(20):e967-e989. PubMed ID: 30943783
[TBL] [Abstract][Full Text] [Related]
27. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
[TBL] [Abstract][Full Text] [Related]
28. Exercise performance of chronic heart failure patients in the early period of support by an axial-flow left ventricular assist device as destination therapy.
Compostella L; Russo N; Setzu T; Compostella C; Bellotto F
Artif Organs; 2014 May; 38(5):366-73. PubMed ID: 24117945
[TBL] [Abstract][Full Text] [Related]
29. The Effect of Left Ventricular Assist Device Therapy on Cardiac Biomarkers: Implications for the Identification of Myocardial Recovery.
Holzhauser L; Kim G; Sayer G; Uriel N
Curr Heart Fail Rep; 2018 Aug; 15(4):250-259. PubMed ID: 29971612
[TBL] [Abstract][Full Text] [Related]
30. Evolution of Left Ventricular Assist Device Therapy for Advanced Heart Failure: A Review.
Miller LW; Rogers JG
JAMA Cardiol; 2018 Jul; 3(7):650-658. PubMed ID: 29710092
[TBL] [Abstract][Full Text] [Related]
31. Effect of Neurohormonal Blockade Drug Therapy on Outcomes and Left Ventricular Function and Structure After Left Ventricular Assist Device Implantation.
Grupper A; Zhao YM; Sajgalik P; Joyce LD; Park SJ; Pereira NL; Stulak JM; Burnett JC; Edwards BS; Daly RC; Kushwaha SS; Schirger JA
Am J Cardiol; 2016 Jun; 117(11):1765-70. PubMed ID: 27079215
[TBL] [Abstract][Full Text] [Related]
32. Echocardiographic predictors of adverse outcomes after continuous left ventricular assist device implantation.
Topilsky Y; Oh JK; Shah DK; Boilson BA; Schirger JA; Kushwaha SS; Pereira NL; Park SJ
JACC Cardiovasc Imaging; 2011 Mar; 4(3):211-22. PubMed ID: 21414567
[TBL] [Abstract][Full Text] [Related]
33. Upstream palliative care for the patient with a left ventricular assist device as destination therapy.
Byram EK
Dimens Crit Care Nurs; 2012; 31(1):18-24. PubMed ID: 22156807
[TBL] [Abstract][Full Text] [Related]
34. Normalisation of haemodynamics in patients with end-stage heart failure with continuous-flow left ventricular assist device therapy.
Gupta S; Woldendorp K; Muthiah K; Robson D; Prichard R; Macdonald PS; Keogh AM; Kotlyar E; Jabbour A; Dhital K; Granger E; Spratt P; Jansz P; Hayward CS
Heart Lung Circ; 2014 Oct; 23(10):963-9. PubMed ID: 24973864
[TBL] [Abstract][Full Text] [Related]
35. Do Patients Supported With Continuous-flow Left Ventricular Assist Device Have a Sufficient Risk of Death to Justify a Priority Allocation? A Propensity Score Matched Analysis of Patients Listed in UNOS Status 2.
Mastrobuoni S; Dell'Aquila AM; Van Caenegem O; Poncelet A; Jacquet LM; Garcia J
Transplantation; 2018 Jun; 102(6):e288-e294. PubMed ID: 29346259
[TBL] [Abstract][Full Text] [Related]
36. Role of percutaneous veno-arterial extracorporeal membrane oxygenation as bridge to left ventricular assist device.
Toda K; Fujita T; Seguchi O; Yanase M; Nakatani T
J Artif Organs; 2018 Mar; 21(1):39-45. PubMed ID: 28871334
[TBL] [Abstract][Full Text] [Related]
37. Does CircuLite Synergy assist device as partial ventricular support have a place in modern management of advanced heart failure?
Mohite PN; Sabashnikov A; Simon AR; Weymann A; Patil NP; Unsoeld B; Bireta C; Popov AF
Expert Rev Med Devices; 2015 Jan; 12(1):49-60. PubMed ID: 25454250
[TBL] [Abstract][Full Text] [Related]
38. Innovations in Ventricular Assist Devices for End-Stage Heart Failure.
Miller RJH; Teuteberg JJ; Hunt SA
Annu Rev Med; 2019 Jan; 70():33-44. PubMed ID: 30296900
[TBL] [Abstract][Full Text] [Related]
39. Right Ventricular Failure After Left Ventricular Assist Device Placement-The Beginning of the End or Just Another Challenge?
Turner KR
J Cardiothorac Vasc Anesth; 2019 Apr; 33(4):1105-1121. PubMed ID: 30197170
[TBL] [Abstract][Full Text] [Related]
40. Clinical Outcomes of Patients Treated With Pulmonary Vasodilators Early and in High Dose After Left Ventricular Assist Device Implantation.
Critoph C; Green G; Hayes H; Baumwol J; Lam K; Larbalestier R; Chih S
Artif Organs; 2016 Jan; 40(1):106-14. PubMed ID: 25994765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
